{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T07:24:31Z","timestamp":1787037871661,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yanzhao Gold Talent Project of Hebei Province","award":["NO.HJZD202506"],"award-info":[{"award-number":["NO.HJZD202506"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02822-6","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:53:12Z","timestamp":1781333592000},"page":"2075-2084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association of high-sensitivity C-reactive protein levels and their changes with heart failure in Chinese diabetes patients"],"prefix":"10.1007","volume":"49","author":[{"given":"Peipei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6574-6706","authenticated-orcid":false,"given":"Youxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"10159","key":"2822_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/s0140-6736(18)32279-7","volume":"10","author":"regional Global","year":"2018","unstructured":"Global regional (2018) National incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet Nov 10(10159):1789\u20131858. https:\/\/doi.org\/10.1016\/s0140-6736(18)32279-7","journal-title":"Lancet Nov"},{"key":"2822_CR2","doi-asserted-by":"publisher","unstructured":"Report on Cardiovascular Health and Diseases in China (2021) : An Updated Summary. Biomed Environ Sci. Jul 20 2022;35(7):573\u2013603. https:\/\/doi.org\/10.3967\/bes2022.079","DOI":"10.3967\/bes2022.079"},{"key":"2822_CR3","doi-asserted-by":"publisher","unstructured":"Kamimura D, Cain LR, Mentz RJ et al (2018) Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study. Circulation. Jun 12. ;137(24):2572\u20132582. https:\/\/doi.org\/10.1161\/circulationaha.117.031912","DOI":"10.1161\/circulationaha.117.031912"},{"issue":"3","key":"2822_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jacc.2008.08.072","volume":"20","author":"JD Flaherty","year":"2009","unstructured":"Flaherty JD, Bax JJ, De Luca L et al (2009) Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol Jan 20(3):254\u2013263. https:\/\/doi.org\/10.1016\/j.jacc.2008.08.072","journal-title":"J Am Coll Cardiol Jan"},{"issue":"8","key":"2822_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","volume":"5","author":"FH Messerli","year":"2017","unstructured":"Messerli FH, Rimoldi SF, Bangalore S (2017) The transition from hypertension to heart failure: contemporary update. JACC Heart Fail Aug 5(8):543\u2013551. https:\/\/doi.org\/10.1016\/j.jchf.2017.04.012","journal-title":"JACC Heart Fail Aug"},{"issue":"8","key":"2822_CR6","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","volume":"27","author":"GA Nichols","year":"2004","unstructured":"Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care Aug 27(8):1879\u20131884. https:\/\/doi.org\/10.2337\/diacare.27.8.1879","journal-title":"Diabetes Care Aug"},{"key":"2822_CR7","doi-asserted-by":"publisher","unstructured":"From AM, Leibson CL, Bursi F et al (Jul 2006) Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 119(7):591\u2013599. https:\/\/doi.org\/10.1016\/j.amjmed.2006.05.024","DOI":"10.1016\/j.amjmed.2006.05.024"},{"issue":"1","key":"2822_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ejhf.679","volume":"19","author":"G Targher","year":"2017","unstructured":"Targher G, Dauriz M, Laroche C et al (2017) In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA heart failure Long-Term registry. Eur J Heart Fail Jan 19(1):54\u201365. https:\/\/doi.org\/10.1002\/ejhf.679","journal-title":"Eur J Heart Fail Jan"},{"issue":"15","key":"2822_CR9","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1053\/euhj.2000.2533","volume":"22","author":"A Mosterd","year":"2001","unstructured":"Mosterd A, Cost B, Hoes AW et al (2001) The prognosis of heart failure in the general population: the Rotterdam study. Eur Heart J Aug 22(15):1318\u20131327. https:\/\/doi.org\/10.1053\/euhj.2000.2533","journal-title":"Eur Heart J Aug"},{"issue":"9","key":"2822_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.2337\/dc17-0509","volume":"40","author":"T Ohkuma","year":"2017","unstructured":"Ohkuma T, Jun M, Woodward M et al (2017) Cardiac stress and inflammatory markers as predictors of heart failure in patients with type 2 diabetes: the ADVANCE trial. Diabetes Care Sep 40(9):1203\u20131209. https:\/\/doi.org\/10.2337\/dc17-0509","journal-title":"Diabetes Care Sep"},{"issue":"1","key":"2822_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1751-7176.2011.00560.x","volume":"14","author":"A Barac","year":"2012","unstructured":"Barac A, Wang H, Shara NM et al (2012) Markers of inflammation, metabolic risk factors, and incident heart failure in American indians: the strong heart study. J Clin Hypertens (Greenwich) Jan 14(1):13\u201319. https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00560.x","journal-title":"J Clin Hypertens (Greenwich) Jan"},{"issue":"3","key":"2822_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jchf.2020.10.013","volume":"9","author":"A Pandey","year":"2021","unstructured":"Pandey A, Vaduganathan M, Patel KV et al (2021) Biomarker-Based risk prediction of incident heart failure in Pre-Diabetes and diabetes. JACC Heart Fail Mar 9(3):215\u2013223. https:\/\/doi.org\/10.1016\/j.jchf.2020.10.013","journal-title":"JACC Heart Fail Mar"},{"issue":"1","key":"2822_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12933-016-0470-x","volume":"3","author":"N Alonso","year":"2016","unstructured":"Alonso N, Lup\u00f3n J, Barallat J et al (2016) Impact of diabetes on the predictive value of heart failure biomarkers. Cardiovasc Diabetol Nov 3(1):151. https:\/\/doi.org\/10.1186\/s12933-016-0470-x","journal-title":"Cardiovasc Diabetol Nov"},{"issue":"11","key":"2822_CR14","doi-asserted-by":"publisher","first-page":"e012486","DOI":"10.1136\/bmjopen-2016-012486","volume":"29","author":"QL Han","year":"2016","unstructured":"Han QL, Wu SL, Liu XX et al (2016) Ideal cardiovascular health score and incident end-stage renal disease in a community-based longitudinal cohort study: the Kailuan study. BMJ Open Nov 29(11):e012486. https:\/\/doi.org\/10.1136\/bmjopen-2016-012486","journal-title":"BMJ Open Nov"},{"issue":"1","key":"2822_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12933-023-01987-1","volume":"30","author":"L Wu","year":"2023","unstructured":"Wu L, Wu M, Zhao D et al (2023) Elevated high-sensitivity C-reactive protein levels increase the risk of new-onset cardiac conduction disorders. Cardiovasc Diabetol Sep 30(1):268. https:\/\/doi.org\/10.1186\/s12933-023-01987-1","journal-title":"Cardiovasc Diabetol Sep"},{"key":"2822_CR16","doi-asserted-by":"publisher","first-page":"1269580","DOI":"10.3389\/fendo.2023.1269580","volume":"14","author":"P Liu","year":"2023","unstructured":"Liu P, Li J, Yang L et al (2023) Association between cumulative uric acid to high-density lipoprotein cholesterol ratio and the incidence and progression of chronic kidney disease. Front Endocrinol (Lausanne) 14:1269580. https:\/\/doi.org\/10.3389\/fendo.2023.1269580","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2822_CR17","doi-asserted-by":"publisher","unstructured":"Wang A, Liu J, Li C et al (2017) Cumulative exposure to High-Sensitivity C-Reactive protein predicts the risk of cardiovascular disease. J Am Heart Assoc Oct 24(10). https:\/\/doi.org\/10.1161\/JAHA.117.005610","DOI":"10.1161\/JAHA.117.005610"},{"issue":"13","key":"2822_CR18","doi-asserted-by":"publisher","first-page":"e020180","DOI":"10.1161\/jaha.120.020180","volume":"6","author":"X Tian","year":"2021","unstructured":"Tian X, Wang A, Wu S et al (2021) Cumulative serum uric acid and its time course are associated with risk of myocardial infarction and All-Cause mortality. J Am Heart Assoc Jul 6(13):e020180. https:\/\/doi.org\/10.1161\/jaha.120.020180","journal-title":"J Am Heart Assoc Jul"},{"key":"2822_CR19","doi-asserted-by":"publisher","first-page":"1222995","DOI":"10.3389\/fcvm.2023.1222995","volume":"10","author":"Z Song","year":"2023","unstructured":"Song Z, Zhao H, Wei Z et al (2023) Mean arterial pressure trajectory with premature cardiovascular disease and all-cause mortality in young adults: the Kailuan prospective cohort study. Front Cardiovasc Med 10:1222995. https:\/\/doi.org\/10.3389\/fcvm.2023.1222995","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2822_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12933-022-01577-7","volume":"27","author":"Z Huang","year":"2022","unstructured":"Huang Z, Ding X, Yue Q et al (2022) Triglyceride-glucose index trajectory and stroke incidence in patients with hypertension: a prospective cohort study. Cardiovasc Diabetol Jul 27(1):141. https:\/\/doi.org\/10.1186\/s12933-022-01577-7","journal-title":"Cardiovasc Diabetol Jul"},{"issue":"11","key":"2822_CR21","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","volume":"26","author":"K Swedberg","year":"2005","unstructured":"Swedberg K, Cleland J, Dargie H et al (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European society of cardiology. Eur Heart J Jun 26(11):1115\u20131140. https:\/\/doi.org\/10.1093\/eurheartj\/ehi204","journal-title":"Eur Heart J Jun"},{"issue":"6","key":"2822_CR22","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.2337\/dc11-0203","volume":"34","author":"N Rognant","year":"2011","unstructured":"Rognant N, Lemoine S, Laville M, Hadj-A\u00efssa A, Dubourg L (2011) Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients. Diabetes Care Jun 34(6):1320\u20131322. https:\/\/doi.org\/10.2337\/dc11-0203","journal-title":"Diabetes Care Jun"},{"issue":"16","key":"2822_CR23","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1161\/01.Cir.0000125690.80303.A8","volume":"27","author":"PM Ridker","year":"2004","unstructured":"Ridker PM, Cook N (2004) Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation Apr 27(16):1955\u20131959. https:\/\/doi.org\/10.1161\/01.Cir.0000125690.80303.A8","journal-title":"Circulation Apr"},{"key":"2822_CR24","doi-asserted-by":"publisher","unstructured":"Molinsky RL, Yuzefpolskaya M, Norby FL Periodontal Status, Protein C-R et al (2022) NT-proBNP, and Incident Heart Failure: The ARIC Study. JACC Heart Fail. Oct ;10(10):731\u2013741. https:\/\/doi.org\/10.1016\/j.jchf.2022.05.008","DOI":"10.1016\/j.jchf.2022.05.008"},{"issue":"3","key":"2822_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ahj.2006.02.023","volume":"152","author":"I Kardys","year":"2006","unstructured":"Kardys I, Knetsch AM, Bleumink GS et al (2006) C-reactive protein and risk of heart failure. The Rotterdam study. Am Heart J Sep 152(3):514\u2013520. https:\/\/doi.org\/10.1016\/j.ahj.2006.02.023","journal-title":"Am Heart J Sep"},{"issue":"1","key":"2822_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ehf2.13088","volume":"8","author":"R Maio","year":"2021","unstructured":"Maio R, Perticone M, Suraci E, Sciacqua A, Sesti G, Perticone F (2021) Endothelial dysfunction and C-reactive protein predict the incidence of heart failure in hypertensive patients. ESC Heart Fail Feb 8(1):399\u2013407. https:\/\/doi.org\/10.1002\/ehf2.13088","journal-title":"ESC Heart Fail Feb"},{"issue":"5","key":"2822_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","volume":"1","author":"PM Burger","year":"2023","unstructured":"Burger PM, Koudstaal S, Mosterd A et al (2023) C-Reactive protein and risk of incident heart failure in patients with cardiovascular disease. J Am Coll Cardiol Aug 1(5):414\u2013426. https:\/\/doi.org\/10.1016\/j.jacc.2023.05.035","journal-title":"J Am Coll Cardiol Aug"},{"issue":"1","key":"2822_CR28","doi-asserted-by":"publisher","first-page":"14118","DOI":"10.1038\/s41598-023-41081-w","volume":"29","author":"HS Lee","year":"2023","unstructured":"Lee HS, Lee JH (2023) Early elevation of high-sensitivity C-reactive protein as a predictor for cardiovascular disease incidence and all-cause mortality: a landmark analysis. Sci Rep Aug 29(1):14118. https:\/\/doi.org\/10.1038\/s41598-023-41081-w","journal-title":"Sci Rep Aug"},{"issue":"5","key":"2822_CR29","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3892\/etm.2015.2730","volume":"10","author":"CH Shi","year":"2015","unstructured":"Shi CH, Wang C, Bai R, Zhang XY, Men LL, Du JL (2015) Associations among glycemic excursions, glycated hemoglobin and high-sensitivity C-reactive protein in patients with poorly controlled type 2 diabetes mellitus. Exp Ther Med Nov 10(5):1937\u20131942. https:\/\/doi.org\/10.3892\/etm.2015.2730","journal-title":"Exp Ther Med Nov"},{"issue":"2","key":"2822_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/01.STR.0000199034.26345.bc","volume":"37","author":"D Sander","year":"2006","unstructured":"Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B (2006) Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke Feb 37(2):351\u2013357. https:\/\/doi.org\/10.1161\/01.STR.0000199034.26345.bc","journal-title":"Stroke Feb"},{"issue":"19","key":"2822_CR31","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1161\/01.CIR.0000095267.24234.00","volume":"11","author":"M Schillinger","year":"2003","unstructured":"Schillinger M, Exner M, Amighi J et al (2003) Joint effects of C-reactive protein and glycated hemoglobin in predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation Nov 11(19):2323\u20132328. https:\/\/doi.org\/10.1161\/01.CIR.0000095267.24234.00","journal-title":"Circulation Nov"},{"issue":"32","key":"2822_CR32","doi-asserted-by":"publisher","first-page":"5695","DOI":"10.2174\/1381612811319320005","volume":"19","author":"TV Fiorentino","year":"2013","unstructured":"Fiorentino TV, Prioletta A, Zuo P, Folli F (2013) Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 19(32):5695\u20135703. https:\/\/doi.org\/10.2174\/1381612811319320005","journal-title":"Curr Pharm Des"},{"issue":"9","key":"2822_CR33","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"29","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res Oct 29(9):1058\u20131070. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.223545","journal-title":"Circ Res Oct"},{"issue":"5","key":"2822_CR34","doi-asserted-by":"publisher","first-page":"614","DOI":"10.21037\/cdt-22-78","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, He S, Liu T et al (2022) Effect of high-sensitivity C-reactive protein on the relationship between haemoglobin A1c and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cohort study. Cardiovasc Diagn Ther Oct 12(5):614\u2013625. https:\/\/doi.org\/10.21037\/cdt-22-78","journal-title":"Cardiovasc Diagn Ther Oct"},{"issue":"1","key":"2822_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","volume":"34","author":"WB Kannel","year":"1974","unstructured":"Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol Jul 34(1):29\u201334. https:\/\/doi.org\/10.1016\/0002-9149(74)90089-7","journal-title":"Am J Cardiol Jul"},{"issue":"9","key":"2822_CR36","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.2337\/diacare.24.9.1614","volume":"24","author":"GA Nichols","year":"2001","unstructured":"Nichols GA, Hillier TA, Erbey JR, Brown JB (2001) Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care Sep 24(9):1614\u20131619. https:\/\/doi.org\/10.2337\/diacare.24.9.1614","journal-title":"Diabetes Care Sep"},{"key":"2822_CR37","doi-asserted-by":"publisher","unstructured":"Lehrke M, Marx N (Jun 2017) Diabetes mellitus and heart failure. Am J Med 130(6s):S40\u2013s50. https:\/\/doi.org\/10.1016\/j.amjmed.2017.04.010","DOI":"10.1016\/j.amjmed.2017.04.010"},{"key":"2822_CR38","doi-asserted-by":"publisher","unstructured":"Nakamura K, Miyoshi T, Yoshida M et al (2022) Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci Mar 25(7). https:\/\/doi.org\/10.3390\/ijms23073587","DOI":"10.3390\/ijms23073587"},{"key":"2822_CR39","doi-asserted-by":"publisher","first-page":"204201882210835","DOI":"10.1177\/20420188221083530","volume":"13","author":"P Ramesh","year":"2022","unstructured":"Ramesh P, Yeo JL, Brady EM, McCann GP (2022) Role of inflammation in diabetic cardiomyopathy. Ther Adv Endocrinol Metab 13:20420188221083530. https:\/\/doi.org\/10.1177\/20420188221083530","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"7","key":"2822_CR40","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1253\/circj.cj-10-1199","volume":"75","author":"Y Mano","year":"2011","unstructured":"Mano Y, Anzai T, Kaneko H et al (2011) Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy. Circ J 75(7):1717\u20131727. https:\/\/doi.org\/10.1253\/circj.cj-10-1199","journal-title":"Circ J"},{"issue":"3","key":"2822_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11892-013-0375-y","volume":"13","author":"E Lontchi-Yimagou","year":"2013","unstructured":"Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP (2013) Diabetes mellitus and inflammation. Curr Diab Rep Jun 13(3):435\u2013444. https:\/\/doi.org\/10.1007\/s11892-013-0375-y","journal-title":"Curr Diab Rep Jun"},{"issue":"4","key":"2822_CR42","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2337\/diabetes.51.4.1157","volume":"51","author":"CD Stehouwer","year":"2002","unstructured":"Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes Apr 51(4):1157\u20131165. https:\/\/doi.org\/10.2337\/diabetes.51.4.1157","journal-title":"Diabetes Apr"},{"issue":"5","key":"2822_CR43","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1161\/01.ATV.0000215951.36219.a4","volume":"26","author":"J de Jager","year":"2006","unstructured":"de Jager J, Dekker JM, Kooy A et al (2006) Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn study. Arterioscler Thromb Vasc Biol May 26(5):1086\u20131093. https:\/\/doi.org\/10.1161\/01.ATV.0000215951.36219.a4","journal-title":"Arterioscler Thromb Vasc Biol May"},{"key":"2822_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/JIR.S387534","volume":"16","author":"G He","year":"2023","unstructured":"He G, Ji R, Huo X et al (2023) Long-Term trajectories of High-Sensitivity C-Reactive protein level among patients with acute heart failure. J Inflamm Res 16:359\u2013371. https:\/\/doi.org\/10.2147\/JIR.S387534","journal-title":"J Inflamm Res"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02822-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02822-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02822-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:29:55Z","timestamp":1787034595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-026-02822-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["2822"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02822-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol complied with the guidelines of the Helsinki Declaration and was approved by the Ethics Committee of Kailuan General Hospital (2006, Approval Number 5).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}